Altavista Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-3,828
Closed -$279K – 146
2017
Q3
$279K Buy
+3,828
New +$276K 0.13% 117
2017
Q1
– Sell
-3,425
Closed -$224K – 128
2016
Q4
$224K Sell
3,425
-317
-8% -$21.7K 0.12% 120
2016
Q3
$277K Buy
3,742
+1
+0% +$74 0.15% 111
2016
Q2
$274K Sell
3,741
-59
-2% -$4.2K 0.15% 109
2016
Q1
$268K Buy
+3,800
New +$253K 0.15% 105
2014
Q4
– Sell
-3,852
Closed -$251K – 112
2014
Q3
$251K Sell
3,852
-200
-5% -$13.2K 0.16% 97
2014
Q2
$276K Sell
4,052
-1,200
-23% -$80.4K 0.17% 98
2014
Q1
$341K Sell
5,252
-300
-5% -$18.9K 0.21% 91
2013
Q4
$362K Sell
5,552
-420
-7% -$26.9K 0.22% 87
2013
Q3
$354K Sell
5,972
-1,090
-15% -$64.6K 0.23% 86
2013
Q2
$405K Buy
+7,062
New +$419K 0.27% 76

Other funds holding CL

Altavista Wealth Management's CL Position: Q4 2017 in Review

Altavista Wealth Management sold out of Colgate-Palmolive (CL) in Q4 2017, closing a stake of 3,828 shares — an estimated $279K sold.

Altavista Wealth Management first reported a position in CL in Q2 2013 and held it in 11 quarters. The position peaked at $405K in Q2 2013. 1,474 funds tracked by Wall St. Rank hold CL as of Q4 2017.

  • Altavista Wealth Management reported no remaining Colgate-Palmolive position as of Q4 2017 after selling out during the quarter.
  • Altavista Wealth Management sold 3,828 Colgate-Palmolive shares in Q4 2017, an estimated $279K.
  • Altavista Wealth Management first reported a position in Colgate-Palmolive in Q2 2013 and held it in 11 quarters.
  • Altavista Wealth Management's Colgate-Palmolive position peaked at $405K in Q2 2013.
  • 1,474 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2017.

Based on Altavista Wealth Management's 13F filing for Q4 2017, filed 13 Feb 2018.